Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,048.00
(
-1.01%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
109.55
(
1.31%
)
Bitcoin
68,564.40
(
1.07%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biocqr

Send PM Follow Ignore
Followers 50
Posts 3530
Boards Moderated 0
Alias Born 08/24/2005

biocqr

Member Level

Re: DewDiligence post# 146549

Friday, 08/03/2012 3:07:53 PM

Friday, August 03, 2012 3:07:53 PM

Post# of 257269

Nucleoside/nucleotide drugs tend to have safety issues. If they didn’t, every company would have one that works well. Efficacy as a polymerase (or reverse-transcriptase) chain blocker is relatively easy to engineer, and these compounds are among the simplest small-molecule drugs.




A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis B

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861763/
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today